Biomarkers and Therapeutical Targets for Prion Diseases
This book explores the intricate landscape of prion diseases, exploring the various methodologies for detecting human and animal prions, emphasizing both current techniques and those under development, as well as emerging techniques and methodologies for biomarker detection in prion diseases, paving...
Spremljeno u:
| Autor kompanije: | |
|---|---|
| Daljnji autori: | , |
| Format: | Elektronički e-knjiga |
| Jezik: | engleski |
| Izdano: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| Izdanje: | 1st ed. 2025. |
| Serija: | Subcellular Biochemistry,
112 |
| Teme: | |
| Online pristup: | https://doi.org/10.1007/978-3-031-97055-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-97055-9 | ||
| 003 | DE-He213 | ||
| 005 | 20260810165839.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 250926s2025 sz | o |||| 0|eng d | ||
| 020 | |a 9783031970559 |9 978-3-031-97055-9 | ||
| 024 | 7 | |a 10.1007/978-3-031-97055-9 |2 doi | |
| 050 | 4 | |a QD431-431.7 | |
| 072 | 7 | |a PSBC |2 bicssc | |
| 072 | 7 | |a SCI049000 |2 bisacsh | |
| 072 | 7 | |a PSB |2 thema | |
| 082 | 0 | 4 | |a 572.6 |2 23 |
| 245 | 1 | 0 | |a Biomarkers and Therapeutical Targets for Prion Diseases |h [electronic resource] / |c edited by Giuseppe Legname, Fabio Moda. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2025. | |
| 300 | |a 1 online resource (VI, 320 p. 32 illus.). |b 26 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b PDF/UA-1 |2 onix | |
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Subcellular Biochemistry, |x 2542-8810 ; |v 112 | |
| 505 | 0 | |a Chapter 1. Advancements in Chronic Wasting Disease (CWD) Prion Detection: Moving Beyond The Gold Standards -- Chapter 2. Diagnosis of Prion Diseases -- Chapter 3. New Therapeutic Modalities in Prion Diseases -- Chapter 4. Prion Disease Diagnostic Biomarker Utility In Pre-Symptomatic Disease -- Chapter 5. Therapeutic Trajectories in Human Prion Diseases -- Chapter 6. Prion and “Prion-Like” Detection: From Conventional Methods To Microfluidics Or Lab-On-Chip Platforms To Monitor Seeding And Spreading Of Misfolded Proteins -- Chapter 7. Tracking Prions by RT-QuIC: an Update -- Chapter 8. Reactive Microglia And Astrocytes As Therapeutic Targets In Prion Diseases -- Chapter 9. Biological Fluid Biomarkers in Human Prion Diseases with a Note on Biosafety -- Chapter 10. Human Genetic Evidence for New Targets in Prion Diseases –Opportunities and Challenges -- Chapter 11. Advancing Prion Diagnostics: RT-QuIC Applications In Peripheral Tissues -- Chapter 12. Detecting the Undetectable: Exploring The Diagnostic Potential Of Protein Misfolding Cyclic Amplification In Human Prion Diseases -- Chapter 13. Seed Amplification Assays As Powerful Tools For Detecting Peripheral Biomarkers In Prion-Like Diseases. | |
| 520 | |a This book explores the intricate landscape of prion diseases, exploring the various methodologies for detecting human and animal prions, emphasizing both current techniques and those under development, as well as emerging techniques and methodologies for biomarker detection in prion diseases, paving the way for improved diagnostic and therapeutic approaches. The rational development of theranostic small molecules for prion diseases is also included, shedding light on potential treatment. It examines the utility of prion disease diagnostic markers in pre-symptomatic disease stages, offering insights into early detection strategies. Pharmacological approaches in prion diseases are explored, along with the potential of Lab-on-Chip platforms for monitoring prion and "prion-like" amyloid assembly and behavior. The role of reactive microglia and astrocytes as therapeutic targets is investigated, highlighting novel avenues for intervention. Furthermore, the book addresses biological fluid biomarkers in human prion diseases, paying special attention to biosafety considerations. Human genetic evidence is analyzed to identify new targets in prion diseases, discussing both opportunities and challenges. The utilization of RT-QuIC analysis of peripheral tissues and PMCA applications in prion disease diagnosis is examined, along with the extension of seed amplification assays for the clinical diagnosis of neurodegenerative disorders beyond prion pathologies. Overall, the book provides a comprehensive overview of biomarkers and therapeutic targets in prion diseases, encapsulating both current knowledge and emerging trends in the field. Chapter 10 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com. | ||
| 532 | 8 | |a Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Proteins . | |
| 650 | 0 | |a Protein folding. | |
| 650 | 0 | |a Proteins. | |
| 650 | 0 | |a Medicine |x Research. | |
| 650 | 0 | |a Biology |x Research. | |
| 650 | 0 | |a Biomolecules. | |
| 650 | 0 | |a Physical biochemistry. | |
| 650 | 0 | |a Macromolecules. | |
| 650 | 1 | 4 | |a Protein Biochemistry. |
| 650 | 2 | 4 | |a Protein Folding. |
| 650 | 2 | 4 | |a Proteins. |
| 650 | 2 | 4 | |a Biomedical Research. |
| 650 | 2 | 4 | |a Structural Biology. |
| 700 | 1 | |a Legname, Giuseppe. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Moda, Fabio. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031970542 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031970566 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031970573 |
| 830 | 0 | |a Subcellular Biochemistry, |x 2542-8810 ; |v 112 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-97055-9 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 912 | |a ZDB-2-236 | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 950 | |a Focus Bundle Molecular and Cellular Life Sciences (SpringerNature-85406) | ||